<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0020">
 <label>4</label>
 <element-citation publication-type="journal" id="sbref0020">
  <person-group person-group-type="author">
   <name>
    <surname>Omrani</surname>
    <given-names>A.S.</given-names>
   </name>
   <name>
    <surname>Saad</surname>
    <given-names>M.M.</given-names>
   </name>
   <name>
    <surname>Baig</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Bahloul</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Abdul-Matin</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Alaidaroos</surname>
    <given-names>A.Y.</given-names>
   </name>
  </person-group>
  <article-title>Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study</article-title>
  <source>Lancet Infect Dis</source>
  <volume>14</volume>
  <issue>11</issue>
  <year>2014</year>
  <fpage>1090</fpage>
  <lpage>1095</lpage>
  <pub-id pub-id-type="doi">10.1016/S1473-3099(14)70920-X</pub-id>
  <pub-id pub-id-type="pmid">25278221</pub-id>
 </element-citation>
</ref>
